Abstract
Since 1999 we have developed three approaches to quantifying each amino acid in a protein as well as a protein in whole based on random mechanisms. With our approaches, we can reliably describe the evolution of a protein family, for example, the hemagglutinins from influenza A viruses along the time course in a 2-dimensional graph, and then we use the fast Fourier transform to find the mutation periodicity in order to time the mutation. In this study, we realize that the changes in quantified randomness in a hemagglutinin family over time is the difference between randomness associated with mutant amino acids and randomness associated with original amino acids. This is a standard mass-balance relationship, by which we can build a differential equation for a hemagglutinin family or a system of differential equations for all hemagglutinins in the family. In this context, the randomness defined by us actually is the entropy, thus we have a general model to describe the evolution, namely, the evolution is the exchange of entropy between protein family and environment through mutations quantified using our approaches.
Keywords: Amino-acid pair predictability, entropy, evolution, hemagglutinin, influenza A virus, quantification, protein, randomness
Protein & Peptide Letters
Title: Describing Evolution of Hemagglutinins from Influenza A Viruses Using a Differential Equation
Volume: 16 Issue: 7
Author(s): Shaomin Yan and Guang Wu
Affiliation:
Keywords: Amino-acid pair predictability, entropy, evolution, hemagglutinin, influenza A virus, quantification, protein, randomness
Abstract: Since 1999 we have developed three approaches to quantifying each amino acid in a protein as well as a protein in whole based on random mechanisms. With our approaches, we can reliably describe the evolution of a protein family, for example, the hemagglutinins from influenza A viruses along the time course in a 2-dimensional graph, and then we use the fast Fourier transform to find the mutation periodicity in order to time the mutation. In this study, we realize that the changes in quantified randomness in a hemagglutinin family over time is the difference between randomness associated with mutant amino acids and randomness associated with original amino acids. This is a standard mass-balance relationship, by which we can build a differential equation for a hemagglutinin family or a system of differential equations for all hemagglutinins in the family. In this context, the randomness defined by us actually is the entropy, thus we have a general model to describe the evolution, namely, the evolution is the exchange of entropy between protein family and environment through mutations quantified using our approaches.
Export Options
About this article
Cite this article as:
Yan Shaomin and Wu Guang, Describing Evolution of Hemagglutinins from Influenza A Viruses Using a Differential Equation, Protein & Peptide Letters 2009; 16 (7) . https://dx.doi.org/10.2174/092986609788681751
DOI https://dx.doi.org/10.2174/092986609788681751 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sugars that Glow in the Dark: Fluorescent Tagged Glucose Bioprobes and their Facilitation of the Drug Discovery Process
Current Medicinal Chemistry Small molecule Screening at Helmholtz Zentrum München – From Biology to Molecules
Combinatorial Chemistry & High Throughput Screening Synthesis, Antioxidant and Antitumor Activity of Some Substituted 9-Anilinoacridine and 4-Anilinoquinolines Derivatives
Current Organic Synthesis Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde
Current Medicinal Chemistry - Anti-Cancer Agents Recent Advances in the Analyses of Carotenoids and Their Role in Human Health
Current Pharmaceutical Analysis Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)
Medicinal Chemistry Personalized Diabetes and Cancer Medicine: A Rationale for Anti-Diabetic Nutrition (Bitter Melon) in a Supportive Setting
Current Cancer Therapy Reviews Metformin Protects the Brain Against the Oxidative Imbalance Promoted by Type 2 Diabetes
Medicinal Chemistry Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Full Factorial Experimental Design for Development and Validation of a RP-HPLC Method for Estimation of Letrozole in Nanoformulations
Current Pharmaceutical Analysis Development of a Plate-Based Assay for High-Content Analysis of Individual Untethered Non-Adherent Cells
Combinatorial Chemistry & High Throughput Screening Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Physico-chemical and Biological Evaluation of Flavonols: Fisetin, Quercetin and Kaempferol Alone and Incorporated in beta Cyclodextrins
Anti-Cancer Agents in Medicinal Chemistry <i>Panax notoginseng</i> Saponins Promote Cell Death and Chemosensitivity in Pancreatic Cancer through the Apoptosis and Autophagy Pathways
Anti-Cancer Agents in Medicinal Chemistry Cutaneous Metabolism in Transdermal Drug Delivery
Current Drug Metabolism Trends in Cell-Based Electrochemical Biosensors
Current Medicinal Chemistry Infectomics in the Discovery and Development of New Antimicrobial Agents
Current Medicinal Chemistry - Anti-Infective Agents Development of a Sensitive Cost-Effective Capture ELISA for Detection of Murine Monoclonal Antibodies - Correlation with SPR Biosensor Technology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry